Sumitomo Mitsui Financial Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $52,641 - $70,928	-96 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $15,473 - $18,159	26 Added 37.14%	96 $66,000
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $5,434 - $6,709	10 Added 16.67%	70 $45,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $34,441 - $40,857	60 New	60 $36,000
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $43,480 - $50,624	-159 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $47,636 - $65,956	159 New	159 $49,000
Q4 2018 Feb 08, 2019	SELL	$335.82 - $403.04 $38,955 - $46,752	-116 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$351.14 - $408.51 $40,732 - $47,387	116 New	116 $47,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Financial Group, Inc. with notifications on news.